Reducing Home Labs for Pediatric Patients With Solid Tumors: Impact of a Novel Clinical Practice Guideline on Safety, Cost, and Quality of Life
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Medicine"
DOI: 10.1002/cam4.71269
Abstract: For pediatric patients with solid tumors, the use of growth factors following chemotherapy evolved from daily filgrastim to pegylated filgrastim. Currently, postâchemotherapy laboratory work is obtained to monitor for transfusion needs rather than count recovery.… read more here.
Keywords: home labs; solid tumors; pediatric patients; patients solid ... See more keywords